📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Indo Borax Appoints Suresh Kalra as MD & CEO with ₹7 Crore Annual Pay Package
Indo Borax & Chemicals is seeking shareholder approval via postal ballot for the appointment of Mr. Suresh Kalra as Managing Director and CEO for a five-year term effective January 23, 2026. The proposed compensation package is substantial, featuring a fixed salary of ₹3.50 crore and a performance-linked bonus of up to ₹3.50 crore tied to EBITDA targets. Furthermore, the appointee is eligible for ESOPs representing up to 5% of the company's fully diluted capital base. Shareholders can cast their votes electronically between March 17 and April 15, 2026.
Key Highlights
Appointment of Suresh Kalra as MD & CEO for a 5-year tenure starting January 23, 2026
Fixed annual salary set at ₹3.50 crore with performance-based annual increments
Performance bonus of up to ₹3.50 crore linked to achieving specific EBITDA targets
Eligibility for equity-linked incentives (ESOPs) up to 5% of the fully diluted capital base
Remote e-voting period scheduled from March 17, 2026, to April 15, 2026
💼 Action for Investors
Investors should support the leadership transition but monitor the 5% potential equity dilution from ESOPs and track if the high compensation leads to improved EBITDA performance.
Indo Borax Appoints Shashikant Bharuka as CFO Effective March 6, 2026
Indo Borax & Chemicals Limited has appointed Mr. Shashikant Bharuka as its new Chief Financial Officer, effective March 6, 2026. Mr. Bharuka is a seasoned professional with over 24 years of post-qualification experience as a CA and CS. He has previously held significant financial roles at major listed pharmaceutical companies including Lupin, Unichem Laboratories, and Ajanta Pharma. This appointment is expected to strengthen the company's financial governance and reporting frameworks.
Key Highlights
Mr. Shashikant Bharuka appointed as CFO and Key Managerial Personnel effective March 6, 2026
Brings over 24 years of experience in finance, accounts, and tax compliance from public listed companies
Previously served 9 years at Unichem Laboratories managing audits and consolidation of foreign subsidiaries
Professional background includes roles at Lupin Limited, Ajanta Pharma, and IPCA Laboratories
The Board approved the appointment following recommendations from the Audit and Nomination committees
💼 Action for Investors
Investors should view this as a positive step towards professionalizing management with an experienced industry veteran. Monitor the company's financial reporting and capital allocation strategies following his transition into the role.
Indo Borax Appoints Mr. Shashikant Bharuka as CFO Effective March 06, 2026
Indo Borax & Chemicals Limited has appointed Mr. Shashikant Bharuka as the Chief Financial Officer (CFO) and Key Managerial Personnel, effective March 06, 2026. Mr. Bharuka is a highly experienced professional with over 24 years of experience in finance and accounts, having worked with major listed firms like Lupin, Unichem Laboratories, and Ajanta Pharma. The Board also approved a draft Postal Ballot Notice for seeking shareholder approval on unspecified resolutions. This leadership addition is expected to strengthen the company's financial reporting and compliance oversight.
Key Highlights
Mr. Shashikant Bharuka appointed as CFO and Key Managerial Personnel effective March 06, 2026
Appointee is a qualified CA and CS with over 24 years of post-qualification experience in finance
Previous experience includes a 9-year tenure at Unichem Laboratories and senior roles at Lupin Limited
The Board approved a draft Postal Ballot Notice for upcoming shareholder resolutions
Appointment was based on recommendations from the Audit and Nomination & Remuneration Committees
💼 Action for Investors
Investors should view the hiring of an experienced professional from larger pharmaceutical firms as a positive step for corporate governance. Monitor the upcoming Postal Ballot for details on other proposed resolutions.
Indo Borax Promoters to Complete 50.80% Stake Sale on Jan 23, 2026
Indo Borax & Chemicals has announced that its promoter group will complete the sale of a 50.80% stake in the company on January 23, 2026. The transaction involves the transfer of 1,63,00,230 equity shares to a consortium including Zenrock Chemicals Private Limited and India Special Assets Fund III. Upon completion, the existing promoters will cease to be in control and will be de-classified from the promoter group. This significant change in ownership marks a major transition for the company's management and strategic oversight.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date finalized as January 23, 2026, via a new SPA Letter Agreement
Purchasers include Zenrock Chemicals and multiple India Special Assets/Situation Funds
Current promoters to be de-classified and will lose control of the company post-transfer
The company itself is not a party to the SPA Letter Agreement but is facilitating the disclosure
💼 Action for Investors
Investors should closely monitor the incoming management's strategic plans and any potential open offer implications. The shift from a family-led promoter group to institutional and private equity ownership could lead to significant changes in operational focus.
Zenrock Chemicals Acquires 50.80% Stake in Indo Borax; Becomes New Promoter
Zenrock Chemicals Private Limited, along with India Special Assets Fund III and other purchasers, has completed the acquisition of 1,63,00,230 equity shares of Indo Borax & Chemicals Limited, representing a 50.80% stake. Following this transfer on January 23, 2026, the Acquirer has taken control of the company and is now classified as the new promoter. The erstwhile promoters, including Mr. Sajal Sushilkumar Jain and others, have exited their holdings and have been de-classified from the promoter group. An open offer for an additional 26.00% stake (83,43,400 shares) is also being undertaken for public shareholders.
Key Highlights
Acquisition of 1,63,00,230 equity shares representing 50.80% of the total paid-up equity capital.
Zenrock Chemicals and associated funds have officially become the new promoters of the company.
The transaction was completed on January 23, 2026, following a Share Purchase Agreement dated December 15, 2025.
An Open Offer is being conducted to acquire up to 83,43,400 additional shares (26.00% stake) from public shareholders.
The former promoter group has been entirely de-classified as they no longer hold shares or exercise control.
💼 Action for Investors
Investors should closely monitor the Open Offer price and the strategic roadmap provided by the new management, Zenrock Chemicals. A change in control by institutional funds often leads to professionalization and potential re-rating of the company.
Indo Borax Promoters to Transfer 50.80% Stake; Completion Set for Jan 23, 2026
Indo Borax & Chemicals has announced the finalization of a major Share Purchase Agreement (SPA) involving the transfer of 1,63,00,230 equity shares. This transaction represents 50.80% of the company's total paid-up equity capital, moving from the existing promoter group to a consortium including Zenrock Chemicals and India Special Assets Fund III. Upon completion on January 23, 2026, the current sellers will cease to be in control and will be de-classified as promoters. This marks a significant shift in the company's ownership and potential management direction.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date finalized as January 23, 2026
Purchasers include Zenrock Chemicals Private Limited and India Special Assets Fund III
Existing promoters to be de-classified and will cease to have control of the company
The company itself is not a party to the SPA Letter Agreement but is the subject of the transfer
💼 Action for Investors
Investors should closely monitor the transition of power and any subsequent changes in business strategy or management by the new majority owners. The stock may see significant volatility as the market assesses the capabilities of the incoming controlling entities.
Indo Borax Promoters to Complete 50.80% Stake Sale on January 23, 2026
Indo Borax & Chemicals has announced that the completion date for a major Share Purchase Agreement (SPA) is set for January 23, 2026. The transaction involves the transfer of 1,63,00,230 equity shares, which represents 50.80% of the company's total paid-up equity capital. The current promoter group, including Mr. Sajal Sushilkumar Jain and others, will sell their stake to a group of purchasers including Zenrock Chemicals and India Special Assets Fund III. Following this completion, the existing sellers will cease to be in control and will be de-classified from the promoter group.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date confirmed as January 23, 2026, via a letter agreement
Purchasers include Zenrock Chemicals Private Limited and India Special Assets Fund III
Current promoters will lose control and be de-classified under SEBI Regulation 31A(10)
The company itself is not a party to the SPA Letter Agreement but is the subject of the transfer
💼 Action for Investors
Investors should closely monitor the transition of management and any strategic shifts introduced by the new majority shareholders. A change in control of over 50% is a critical event that may lead to significant changes in the company's operational direction.
Indo Borax Q3 FY26 Net Profit Rises 2.2% YoY to ₹9.27 Cr; Revenue Up 9.3%
Indo Borax & Chemicals reported a steady year-on-year performance for Q3 FY26, with consolidated revenue growing 9.3% to ₹41.02 crore. Consolidated net profit saw a marginal increase of 2.2% YoY, reaching ₹9.27 crore. The company experienced a significant sequential (QoQ) decline in performance because its Pithampur plant was shut down for 40 days (Oct 14 to Nov 22, 2025) for planned maintenance. Additionally, the company recognized a one-time benefit of ₹27.97 lakhs due to adjustments related to the New Labour Codes.
Key Highlights
Consolidated Revenue from Operations increased 9.3% YoY to ₹41.02 crore from ₹37.51 crore.
Consolidated Net Profit grew 2.2% YoY to ₹9.27 crore, while EPS stood at ₹2.89.
Pithampur plant shutdown for 40 days for boiler maintenance led to a ~29% QoQ revenue decline.
Nine-month consolidated net profit reached ₹35.74 crore, up from ₹32.26 crore in the previous year.
One-time decrease in employee benefit provision of ₹27.97 lakhs recognized due to New Labour Codes.
💼 Action for Investors
The sharp sequential decline is attributable to a one-off plant maintenance shutdown rather than a loss of demand. Investors should monitor Q4 results to ensure production levels and margins return to normal operating capacity.
Zenrock Chemicals and Edelweiss Funds Launch Open Offer for 26% of Indo Borax at ₹256.30/Share
Zenrock Chemicals Private Limited, along with Edelweiss-backed funds, has issued a Draft Letter of Offer (DLOF) to acquire a 26% stake in Indo Borax & Chemicals Limited. The open offer is priced at ₹256.30 per share, targeting the acquisition of up to 83,43,400 equity shares. This mandatory offer follows the initial announcement in mid-December 2025 and is triggered by substantial acquisition regulations. The tendering period for public shareholders is tentatively scheduled to open on February 6, 2026.
Key Highlights
Open offer price fixed at ₹256.30 per equity share of face value ₹1 each
Acquisition target of 83,43,400 shares representing 26% of the company's voting share capital
Acquirers include Zenrock Chemicals and three Edelweiss-managed Alternative Investment Funds (PACs)
The total offer is payable in cash and is not subject to any minimum level of acceptance
Tentative schedule sets the offer opening date for February 6, 2026, and closing on February 19, 2026
💼 Action for Investors
Investors should compare the offer price of ₹256.30 against the current market price to evaluate the premium or discount. It is advisable to wait for the recommendation of the Committee of Independent Directors, due by February 4, 2026, before deciding to tender shares.
Zenrock Chemicals and PACs Launch Open Offer for 26% Stake in Indo Borax at ₹162/Share
Zenrock Chemicals Private Limited, along with India Special Assets Fund III and other PACs, has announced an open offer to acquire up to 83,43,400 equity shares of Indo Borax & Chemicals Limited. This represents 26% of the company's voting share capital. The offer price is set at ₹162 per share, to be paid in cash, following a substantial acquisition agreement. This move indicates a significant change in the shareholding structure and potential management control of the company.
Key Highlights
Open offer to acquire up to 83,43,400 equity shares, representing 26% of the total voting capital.
Offer price fixed at ₹162 per equity share, payable in cash.
Acquirers include Zenrock Chemicals Private Limited and three India Special Assets Funds (PACs).
The offer is triggered under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011.
IIFL Capital Services Limited is acting as the Manager to the Open Offer.
💼 Action for Investors
Investors should monitor the market price relative to the ₹162 offer price to determine if tendering shares is beneficial. The involvement of special situation funds suggests a potential strategic turnaround or value unlocking that warrants a close watch on future management commentary.
Zenrock Chemicals to Acquire 50.8% Stake in Indo Borax; Open Offer Launched at ₹256.30
Zenrock Chemicals Private Limited, along with three Special Assets Funds, has entered into a Share Purchase Agreement to acquire a 50.80% controlling stake in Indo Borax & Chemicals Limited from its current promoters. This transaction has triggered a mandatory open offer for an additional 26% stake (83,43,400 shares) from public shareholders at a price of ₹256.30 per share. The total consideration for the open offer is approximately ₹213.84 crores, while the initial promoter stake acquisition is valued at ₹417.77 crores. The acquirers have stated their intention to maintain the company's listed status following the completion of the offer.
Key Highlights
Acquisition of 1,63,00,230 equity shares (50.80% stake) from existing promoters at ₹256.30 per share.
Mandatory Open Offer launched for 83,43,400 shares (26.00% stake) at the same price of ₹256.30.
Total transaction value including the Open Offer is estimated at approximately ₹631.61 crores.
Acquirers include Zenrock Chemicals and three PACs: India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund.
The offer price of ₹256.30 will be paid entirely in cash to validly tendering public shareholders.
💼 Action for Investors
Investors should monitor the stock's market price relative to the ₹256.30 offer price; if the market price remains significantly lower, tendering in the open offer may be beneficial. Long-term holders should evaluate the track record of the new incoming promoters and their strategic vision for the company's chemical business.
Indo Borax Promoters to Sell 50.80% Stake to Zenrock Chemicals at INR 256.30/Share
The promoter group of Indo Borax & Chemicals has signed a Share Purchase Agreement to sell their entire 50.80% stake (1,63,00,230 shares) to Zenrock Chemicals and associated funds. The transaction is priced at INR 256.30 per share, which triggers a mandatory open offer for an additional 26% stake from public shareholders. Following the completion of this deal, the current promoters will exit the company entirely, leading to a complete change in management and control. Zenrock Chemicals will appoint three nominee directors to the board, while existing promoter-directors will resign.
Key Highlights
Promoters to divest 1,63,00,230 shares, representing 50.80% of the total paid-up equity capital.
The transaction price is set at INR 256.30 per share under the Share Purchase Agreement (SPA).
Acquirers will launch a mandatory Open Offer for an additional 26% of the expanded voting share capital.
Complete management transition planned with the resignation of Mr. Sajal Jain and Mr. Govind Ramlal Parmar.
New acquirers (Zenrock Chemicals and ISAF III) will appoint 3 nominee directors to the Board.
💼 Action for Investors
Investors should evaluate the open offer price of INR 256.30 against the current market price to decide on participating in the exit opportunity. The entry of new institutional-backed management could potentially re-rate the stock, but investors should watch for the new leadership's strategic roadmap.
INDOBORAX: Promoter Group to Sell 50.80% Stake, Open Offer Triggered
Indo Borax & Chemicals Limited announced that its promoter group will sell an aggregate of 1,63,00,230 equity shares, constituting approximately 50.80% of the total paid-up equity share capital, to Zenrock Chemicals Private Limited, India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund. This transaction triggers an open offer for acquisition of an additional 26% of the expanded voting share capital, in accordance with SEBI regulations. The per share price for the sale is INR 256.30. Upon completion, the sellers will be de-classified from being promoters.
Key Highlights
Promoter group to sell 50.80% stake in INDOBORAX.
Open offer triggered for an additional 26% of the expanded voting share capital.
Sale involves 1,63,00,230 equity shares.
Per share price for the sale is INR 256.30.
Sellers will be de-classified from promoter group after the transaction.
💼 Action for Investors
Investors should closely monitor the open offer details and evaluate whether to participate, considering the offer price and their investment strategy. Keep an eye on the new management's strategy post-acquisition.